BR112016027901A2 - Compostos - Google Patents

Compostos

Info

Publication number
BR112016027901A2
BR112016027901A2 BR112016027901A BR112016027901A BR112016027901A2 BR 112016027901 A2 BR112016027901 A2 BR 112016027901A2 BR 112016027901 A BR112016027901 A BR 112016027901A BR 112016027901 A BR112016027901 A BR 112016027901A BR 112016027901 A2 BR112016027901 A2 BR 112016027901A2
Authority
BR
Brazil
Prior art keywords
compounds
Prior art date
Application number
BR112016027901A
Other languages
English (en)
Other versions
BR112016027901B1 (pt
Inventor
Jean-Louis Reymond
Simon Nicolussi
Jurg Gertsch
Original Assignee
Univ Bern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bern filed Critical Univ Bern
Publication of BR112016027901A2 publication Critical patent/BR112016027901A2/pt
Publication of BR112016027901B1 publication Critical patent/BR112016027901B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BR112016027901-8A 2014-05-28 2015-05-28 Compostos derivados de tiazolidinona que inibem absorção celular de anandamida e uso destes compostos BR112016027901B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14170449.4 2014-05-28
EP14170449 2014-05-28
EP14171024.4 2014-06-03
EP14171024 2014-06-03
PCT/EP2015/061915 WO2015181337A1 (en) 2014-05-28 2015-05-28 Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation

Publications (2)

Publication Number Publication Date
BR112016027901A2 true BR112016027901A2 (pt) 2017-08-22
BR112016027901B1 BR112016027901B1 (pt) 2023-12-12

Family

ID=54698145

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016027901-8A BR112016027901B1 (pt) 2014-05-28 2015-05-28 Compostos derivados de tiazolidinona que inibem absorção celular de anandamida e uso destes compostos

Country Status (15)

Country Link
US (3) US10155754B2 (pt)
EP (2) EP3148990B1 (pt)
JP (1) JP6671301B2 (pt)
CN (1) CN106660976B (pt)
AU (2) AU2015265865B2 (pt)
BR (1) BR112016027901B1 (pt)
CA (1) CA2950354C (pt)
DK (1) DK3148990T3 (pt)
ES (1) ES2910455T3 (pt)
HR (1) HRP20220490T8 (pt)
MX (2) MX2016015627A (pt)
PL (1) PL3148990T3 (pt)
RS (1) RS63107B1 (pt)
RU (1) RU2734253C2 (pt)
WO (1) WO2015181337A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2845636T3 (es) * 2014-05-28 2021-07-27 Univ Bern Tiazolidinonas como inhibidores de la captación celular de anandamida y su uso en el tratamiento de trastornos psiquiátricos o neurológicos y de inflamación, en particular de neuroinflamación

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739888A (en) * 1954-03-29 1956-03-27 Eastman Kodak Co Photographic elements containing thiazolidine derivatives
US2798067A (en) * 1954-03-29 1957-07-02 Eastman Kodak Co 2-imino-4-thiazolidones and preparation
PT1567112E (pt) * 2002-11-22 2009-01-08 Smithkline Beecham Corp Novos compostos químicos
EP1660459A2 (en) * 2003-08-12 2006-05-31 Amgen inc. Arylsulfonamidobenzylic compounds
US20050042213A1 (en) * 2003-08-14 2005-02-24 Insight Biopharmaceuticals Ltd. Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
USRE43728E1 (en) * 2003-11-21 2012-10-09 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
WO2007059195A1 (en) 2005-11-14 2007-05-24 University Of Southern California Integrin-binding small molecules
WO2008100977A2 (en) * 2007-02-14 2008-08-21 N.V. Organon Carbamates therapeutic release agents as amidase inhibitors
WO2009137133A2 (en) * 2008-02-14 2009-11-12 University Of Washington 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection
EP2435019B1 (en) 2009-05-29 2015-09-23 Dr. August Wolff GmbH & Co. KG Arzneimittel Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics
GB201007187D0 (en) * 2010-04-29 2010-06-09 Iti Scotland Ltd Ubiquitination modulators

Also Published As

Publication number Publication date
MX2020013537A (es) 2021-02-26
US10155754B2 (en) 2018-12-18
US10392377B2 (en) 2019-08-27
US20170197952A1 (en) 2017-07-13
JP2017516795A (ja) 2017-06-22
RU2016147230A3 (pt) 2018-12-25
RS63107B1 (sr) 2022-04-29
US20190119265A1 (en) 2019-04-25
HRP20220490T8 (hr) 2022-06-10
BR112016027901B1 (pt) 2023-12-12
ES2910455T3 (es) 2022-05-12
MX2016015627A (es) 2017-05-04
AU2015265865A1 (en) 2016-12-15
RU2734253C2 (ru) 2020-10-13
WO2015181337A1 (en) 2015-12-03
AU2020213369B2 (en) 2022-09-22
DK3148990T3 (da) 2022-04-11
HRP20220490T1 (hr) 2022-05-27
AU2015265865B2 (en) 2020-05-07
EP3148990B1 (en) 2022-01-19
US20190382397A1 (en) 2019-12-19
CN106660976A (zh) 2017-05-10
RU2016147230A (ru) 2018-07-02
CN106660976B (zh) 2019-11-26
US10774077B2 (en) 2020-09-15
PL3148990T3 (pl) 2022-05-30
EP3148990A1 (en) 2017-04-05
CA2950354C (en) 2023-10-03
CA2950354A1 (en) 2015-12-03
JP6671301B2 (ja) 2020-03-25
AU2020213369A1 (en) 2020-08-27
EP4011879A1 (en) 2022-06-15

Similar Documents

Publication Publication Date Title
DK3134402T3 (da) 4-amino-imidazoquinolinforbindelser
DK3183051T3 (da) Væske-til-luftmembranenergivekslere
DK3211743T3 (da) Ø-til-netværk-omskiftningsfremgangsmåde
DK3222714T3 (da) Phytasemutanter
DK3119396T3 (da) Muscarinreceptoragonister
DK3006072T3 (da) Karadgang
CL2016002165A1 (es) Compuestos de aminocarbonilcarbamato
DE112015001664A5 (de) Betätigungsaktuator
BR112016030730A2 (pt) Composto
DK3191466T3 (da) Azetidinyloxyphenylpyrrolidinforbindelser
DK3183340T3 (da) Termolabile exonukleaser
DK3154703T3 (da) Fuldkappe-snekkecentrifuge
DK3110439T3 (da) Pcsk9-vacciner
DE112015005041A5 (de) Gargerätevorrichtung
DE102014000623A8 (de) Halbhohlnietelement
DK3009858T3 (da) Skyradar
DE112015001633A5 (de) Betätigungsaktuator
DK3447493T3 (da) Proteinrettede ortologer
ES1133830Y (es) Columbario
BR112016027901A2 (pt) Compostos
DK3091875T3 (da) Vipbar taburet
DE112015005055A5 (de) Gargerätevorrichtung
DK3191825T3 (da) Kreatininbiosensor
ES1137381Y (es) Trompo
ES1136185Y (es) Huevera

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/05/2015, OBSERVADAS AS CONDICOES LEGAIS